Sánchez MCM

Language: Spanish
References: 11
Page: 54-55
PDF size: 95.18 Kb.

REFERENCES

1. Charcot JM. Lectures on the diseases of the nervous system, delivered at La Salpetriere, Sigerson G, trans. Philadelphia, PA: Henry C. Lea; 1879.

2. Oleen-Burkey M, Castelli-Haley J, Lage MJ, Johnson KP. Burden of a multiple sclerosis relapse: the patient's perspective. Patient. 2012; 5 (1): 57-69. doi: 10.2165/11592160-000000000-00000.

3. Berkovich RR. Acute multiple sclerosis relapse. Continuum (Minneap Minn). 2016; 22 (3): 799-814. doi: 10.1212/CON.0000000000000330.

4. Berkovich R. Treatment of acute relapses in multiple sclerosis. Neurotherapeutics. 2013; 10 (1): 97-105. doi: 10.1007/s13311-012-0160-7.

5. Repovic P, Lublin FD. Treatment of multiple sclerosis exacerbations. Neurol Clin. 2011; 29 (2): 389-400. doi: 10.1016/j.ncl.2010.12.012.

6. Kalincik T, Buzzard K, Jokubaitis V, Trojano M, Duquette P, Izquierdo G, et al. Risk of relapse phenotype recurrence in multiple sclerosis. Mult Scler. 2014; 20 (11): 1511-1522.

7. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol. 2002; 2 (2): 85-95.

8. Miller H, Newell DJ, Ridley A. Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.). Lancet. 1961; 2 (7212): 1120-1122. doi: 10.1016/s0140-6736(61)91030-3.

9. Burton JM, O'Connor PW, Hohol M, Beyene J. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database Syst Rev. 2012; 12: CD006921.

10. Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999; 46 (6): 878-886. doi: 10.1002/1531-8249(199912)46:6<878::aid-ana10>3.0.co;2-q.

11. Sorensen PS, Haas J, Sellebjerg F, Olsson T, Ravnborg M; TARIMS Study Group. IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS. Neurology. 2004; 63 (11): 2028-2033. doi: 10.1212/01.wnl.0000145798.61383.39.